|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/37 | |
| G01N 21/47 | |||
| G01N 33/66 |
| (11) | Number of the document | 3221465 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15802326.7 |
| Date of filing the European patent application | 2015-11-19 | |
| (97) | Date of publication of the European application | 2017-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/061684 |
| Date | 2015-11-19 |
| (87) | Number | WO 2016/081770 |
| Date | 2016-05-26 |
| (30) | Number | Date | Country code |
| 201462082014 P | 2014-11-19 | US |
| (72) |
CHEMMALIL, Letha, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS |
| QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS |